Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2024-2-6

Curated date: 2023/10/27

Curator: MyleeeA

Revision editor(s): MyleeeA, LGeistlinger, Folakunmi

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
COVID-19 2019 novel coronavirus,2019 novel coronavirus infection,2019-nCoV,2019-nCoV infection,beta-CoV,beta-CoVs,betacoronavirus,coronavirus disease 2019,SARS-coronavirus 2,SARS-CoV-2,severe acute respiratory syndrome coronavirus 2,severe acute respiratory syndrome coronavirus 2 infectious disease,β-coronavirus,β-CoV,β-CoVs,COVID-19,cOVID-19
Group 0 name Corresponds to the control (unexposed) group for case-control studies
samples from Healthy patients
Group 1 name Corresponds to the case (exposed) group for case-control studies
Feces samples from COVID-19 patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
The samples were collected from a cohort of patients diagnosed with COVID-19, classified into three severity degrees: mild, moderate, and severe illness, based on specific criteria.
Group 0 sample size Number of subjects in the control (unexposed) group
40
Group 1 sample size Number of subjects in the case (exposed) group
112
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
N/A

Lab analysis

Sequencing type
PCR
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2024-2-6

Curated date: 2023/10/27

Curator: MyleeeA

Revision editor(s): MyleeeA, Folakunmi

Source: Within Results text ("Alteration of microbial composition in COVID-19 patients is associated with disease severity", lines 13-16) Description: Altered microbial composition associated with disease severity

Description: Altered microbial composition associated with disease severity

Abundance in Group 1: increased abundance in Feces samples from COVID-19 patients

NCBI Quality ControlLinks
Halomonas
Pseudomonas

Revision editor(s): MyleeeA, Folakunmi

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2024-2-6

Curated date: 2023/10/27

Curator: MyleeeA

Revision editor(s): MyleeeA, Folakunmi

Source: Within Results text ("Alteration of microbial composition in COVID-19 patients is associated with disease severity", lines 13-16)

Description: Altered microbial composition associated with disease severity.

Abundance in Group 1: decreased abundance in Feces samples from COVID-19 patients

NCBI Quality ControlLinks
Anaerostipes
Bifidobacterium
Eggerthella
Enterocloster
Faecalibacterium
Flavonifractor
Lachnoclostridium
Lachnospira
Parabacteroides
Roseburia

Revision editor(s): MyleeeA, Folakunmi